Insmed Inc. buy The Goldman Sachs Group, Inc.
Start price
15.12.25
/
50%
€170.00
Target price
15.12.26
€219.76
Performance (%)
-27.06%
Price
08:47
?
Summary
This prediction is currently active. The price of Insmed Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -27.06%. This prediction currently runs until 15.12.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -4.000% | -4.000% |
| iShares Core DAX® | -3.520% | -4.987% |
| iShares Nasdaq 100 | 0.261% | 1.102% |
| iShares Nikkei 225® | -4.953% | -3.352% |
| iShares S&P 500 | -0.823% | -0.042% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $225.00 to $258.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat